nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP1A2—Dacarbazine—muscle cancer	0.243	0.567	CbGbCtD
Moclobemide—CYP1A2—Etoposide—muscle cancer	0.119	0.277	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—muscle cancer	0.0669	0.156	CbGbCtD
Moclobemide—Anorectal discomfort—Etoposide—muscle cancer	0.0164	0.0286	CcSEcCtD
Moclobemide—Rectal tenesmus—Doxorubicin—muscle cancer	0.0124	0.0218	CcSEcCtD
Moclobemide—Appetite absent—Methotrexate—muscle cancer	0.0108	0.0188	CcSEcCtD
Moclobemide—Urine output increased—Vincristine—muscle cancer	0.00998	0.0175	CcSEcCtD
Moclobemide—Proctalgia—Doxorubicin—muscle cancer	0.00989	0.0173	CcSEcCtD
Moclobemide—Polyuria—Vincristine—muscle cancer	0.00912	0.016	CcSEcCtD
Moclobemide—Anorectal discomfort—Doxorubicin—muscle cancer	0.00848	0.0149	CcSEcCtD
Moclobemide—Gingivitis—Methotrexate—muscle cancer	0.00682	0.0119	CcSEcCtD
Moclobemide—Stomatitis—Dactinomycin—muscle cancer	0.00674	0.0118	CcSEcCtD
Moclobemide—Dysuria—Vincristine—muscle cancer	0.00648	0.0113	CcSEcCtD
Moclobemide—Dermatitis atopic—Doxorubicin—muscle cancer	0.00627	0.011	CcSEcCtD
Moclobemide—Stomatitis—Vincristine—muscle cancer	0.00602	0.0105	CcSEcCtD
Moclobemide—Sweating—Vincristine—muscle cancer	0.00592	0.0104	CcSEcCtD
Moclobemide—Gingivitis—Doxorubicin—muscle cancer	0.00591	0.0103	CcSEcCtD
Moclobemide—Flushing—Dactinomycin—muscle cancer	0.00576	0.0101	CcSEcCtD
Moclobemide—Hepatic enzyme increased—Methotrexate—muscle cancer	0.00566	0.00991	CcSEcCtD
Moclobemide—Dysarthria—Methotrexate—muscle cancer	0.00566	0.00991	CcSEcCtD
Moclobemide—Hallucination—Vincristine—muscle cancer	0.00552	0.00966	CcSEcCtD
Moclobemide—Ill-defined disorder—Dactinomycin—muscle cancer	0.00501	0.00877	CcSEcCtD
Moclobemide—Dysarthria—Doxorubicin—muscle cancer	0.0049	0.00858	CcSEcCtD
Moclobemide—Stomatitis—Etoposide—muscle cancer	0.00488	0.00854	CcSEcCtD
Moclobemide—Malaise—Dactinomycin—muscle cancer	0.00487	0.00853	CcSEcCtD
Moclobemide—Urine output increased—Methotrexate—muscle cancer	0.00484	0.00848	CcSEcCtD
Moclobemide—Myalgia—Dactinomycin—muscle cancer	0.0046	0.00805	CcSEcCtD
Moclobemide—Discomfort—Dactinomycin—muscle cancer	0.00454	0.00795	CcSEcCtD
Moclobemide—Agitation—Vincristine—muscle cancer	0.00443	0.00776	CcSEcCtD
Moclobemide—Polyuria—Methotrexate—muscle cancer	0.00443	0.00775	CcSEcCtD
Moclobemide—Flushing—Etoposide—muscle cancer	0.00417	0.0073	CcSEcCtD
Moclobemide—Hypertension—Vincristine—muscle cancer	0.00417	0.00729	CcSEcCtD
Moclobemide—Myalgia—Vincristine—muscle cancer	0.00411	0.00719	CcSEcCtD
Moclobemide—Visual disturbance—Methotrexate—muscle cancer	0.0041	0.00718	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00402	0.00703	CcSEcCtD
Moclobemide—Osteoarthritis—Methotrexate—muscle cancer	0.00389	0.00681	CcSEcCtD
Moclobemide—Decreased appetite—Dactinomycin—muscle cancer	0.00383	0.00671	CcSEcCtD
Moclobemide—Dysgeusia—Etoposide—muscle cancer	0.00383	0.0067	CcSEcCtD
Moclobemide—Hyperhidrosis—Vincristine—muscle cancer	0.00381	0.00667	CcSEcCtD
Moclobemide—Fatigue—Dactinomycin—muscle cancer	0.0038	0.00665	CcSEcCtD
Moclobemide—Irritability—Methotrexate—muscle cancer	0.00371	0.0065	CcSEcCtD
Moclobemide—Hypotension—Vincristine—muscle cancer	0.00368	0.00644	CcSEcCtD
Moclobemide—Feeling abnormal—Dactinomycin—muscle cancer	0.00363	0.00636	CcSEcCtD
Moclobemide—Ill-defined disorder—Etoposide—muscle cancer	0.00363	0.00635	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0036	0.00631	CcSEcCtD
Moclobemide—Hot flush—Doxorubicin—muscle cancer	0.0036	0.0063	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00359	0.00628	CcSEcCtD
Moclobemide—Menopausal symptoms—Doxorubicin—muscle cancer	0.00357	0.00625	CcSEcCtD
Moclobemide—Insomnia—Vincristine—muscle cancer	0.00356	0.00624	CcSEcCtD
Moclobemide—Paraesthesia—Vincristine—muscle cancer	0.00354	0.00619	CcSEcCtD
Moclobemide—Malaise—Etoposide—muscle cancer	0.00352	0.00617	CcSEcCtD
Moclobemide—Abdominal pain—Dactinomycin—muscle cancer	0.00348	0.0061	CcSEcCtD
Moclobemide—Loss of consciousness—Etoposide—muscle cancer	0.00344	0.00602	CcSEcCtD
Moclobemide—Decreased appetite—Vincristine—muscle cancer	0.00342	0.00599	CcSEcCtD
Moclobemide—Fatigue—Vincristine—muscle cancer	0.0034	0.00594	CcSEcCtD
Moclobemide—Hypertension—Etoposide—muscle cancer	0.00337	0.00591	CcSEcCtD
Moclobemide—Constipation—Vincristine—muscle cancer	0.00337	0.0059	CcSEcCtD
Moclobemide—Osteoarthritis—Doxorubicin—muscle cancer	0.00337	0.00589	CcSEcCtD
Moclobemide—Chest pain—Etoposide—muscle cancer	0.00333	0.00583	CcSEcCtD
Moclobemide—Migraine—Doxorubicin—muscle cancer	0.00331	0.0058	CcSEcCtD
Moclobemide—Discomfort—Etoposide—muscle cancer	0.00329	0.00576	CcSEcCtD
Moclobemide—Gastrointestinal pain—Vincristine—muscle cancer	0.00322	0.00564	CcSEcCtD
Moclobemide—Confusional state—Etoposide—muscle cancer	0.00322	0.00563	CcSEcCtD
Moclobemide—Asthenia—Dactinomycin—muscle cancer	0.00316	0.00554	CcSEcCtD
Moclobemide—Dysuria—Methotrexate—muscle cancer	0.00314	0.0055	CcSEcCtD
Moclobemide—Tachycardia—Etoposide—muscle cancer	0.00311	0.00545	CcSEcCtD
Moclobemide—Abdominal pain—Vincristine—muscle cancer	0.00311	0.00545	CcSEcCtD
Moclobemide—Dry skin—Doxorubicin—muscle cancer	0.00309	0.0054	CcSEcCtD
Moclobemide—Hyperhidrosis—Etoposide—muscle cancer	0.00308	0.0054	CcSEcCtD
Moclobemide—Diarrhoea—Dactinomycin—muscle cancer	0.00302	0.00528	CcSEcCtD
Moclobemide—Drowsiness—Methotrexate—muscle cancer	0.003	0.00525	CcSEcCtD
Moclobemide—Hypotension—Etoposide—muscle cancer	0.00298	0.00522	CcSEcCtD
Moclobemide—Gastritis—Doxorubicin—muscle cancer	0.00298	0.00522	CcSEcCtD
Moclobemide—Abdominal distension—Doxorubicin—muscle cancer	0.00293	0.00513	CcSEcCtD
Moclobemide—Stomatitis—Methotrexate—muscle cancer	0.00292	0.00511	CcSEcCtD
Moclobemide—Conjunctivitis—Methotrexate—muscle cancer	0.00291	0.0051	CcSEcCtD
Moclobemide—Sweating—Methotrexate—muscle cancer	0.00287	0.00503	CcSEcCtD
Moclobemide—Paraesthesia—Etoposide—muscle cancer	0.00286	0.00502	CcSEcCtD
Moclobemide—Dyspnoea—Etoposide—muscle cancer	0.00284	0.00498	CcSEcCtD
Moclobemide—Somnolence—Etoposide—muscle cancer	0.00284	0.00497	CcSEcCtD
Moclobemide—Angina pectoris—Doxorubicin—muscle cancer	0.00283	0.00496	CcSEcCtD
Moclobemide—Asthenia—Vincristine—muscle cancer	0.00283	0.00495	CcSEcCtD
Moclobemide—Vomiting—Dactinomycin—muscle cancer	0.0028	0.00491	CcSEcCtD
Moclobemide—Rash—Dactinomycin—muscle cancer	0.00278	0.00487	CcSEcCtD
Moclobemide—Decreased appetite—Etoposide—muscle cancer	0.00277	0.00486	CcSEcCtD
Moclobemide—Fatigue—Etoposide—muscle cancer	0.00275	0.00482	CcSEcCtD
Moclobemide—Constipation—Etoposide—muscle cancer	0.00273	0.00478	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—muscle cancer	0.00272	0.00476	CcSEcCtD
Moclobemide—Diarrhoea—Vincristine—muscle cancer	0.00269	0.00472	CcSEcCtD
Moclobemide—Feeling abnormal—Etoposide—muscle cancer	0.00263	0.0046	CcSEcCtD
Moclobemide—Nausea—Dactinomycin—muscle cancer	0.00262	0.00458	CcSEcCtD
Moclobemide—Gastrointestinal pain—Etoposide—muscle cancer	0.00261	0.00457	CcSEcCtD
Moclobemide—Dizziness—Vincristine—muscle cancer	0.0026	0.00456	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—muscle cancer	0.00259	0.00454	CcSEcCtD
Moclobemide—Visual impairment—Methotrexate—muscle cancer	0.00259	0.00454	CcSEcCtD
Moclobemide—Urticaria—Etoposide—muscle cancer	0.00253	0.00444	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—muscle cancer	0.00253	0.00443	CcSEcCtD
Moclobemide—Abdominal pain—Etoposide—muscle cancer	0.00252	0.00442	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—muscle cancer	0.00252	0.00442	CcSEcCtD
Moclobemide—Tinnitus—Methotrexate—muscle cancer	0.00251	0.00439	CcSEcCtD
Moclobemide—Vomiting—Vincristine—muscle cancer	0.0025	0.00438	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—muscle cancer	0.00249	0.00435	CcSEcCtD
Moclobemide—Rash—Vincristine—muscle cancer	0.00248	0.00435	CcSEcCtD
Moclobemide—Dermatitis—Vincristine—muscle cancer	0.00248	0.00434	CcSEcCtD
Moclobemide—Headache—Vincristine—muscle cancer	0.00247	0.00432	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—muscle cancer	0.00237	0.00415	CcSEcCtD
Moclobemide—Nausea—Vincristine—muscle cancer	0.00234	0.0041	CcSEcCtD
Moclobemide—Dysgeusia—Methotrexate—muscle cancer	0.00229	0.00401	CcSEcCtD
Moclobemide—Asthenia—Etoposide—muscle cancer	0.00229	0.00401	CcSEcCtD
Moclobemide—Pruritus—Etoposide—muscle cancer	0.00226	0.00395	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—muscle cancer	0.00224	0.00393	CcSEcCtD
Moclobemide—Vision blurred—Methotrexate—muscle cancer	0.00221	0.00386	CcSEcCtD
Moclobemide—Diarrhoea—Etoposide—muscle cancer	0.00218	0.00382	CcSEcCtD
Moclobemide—Ill-defined disorder—Methotrexate—muscle cancer	0.00217	0.0038	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—muscle cancer	0.00217	0.0038	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—muscle cancer	0.00216	0.00378	CcSEcCtD
Moclobemide—Malaise—Methotrexate—muscle cancer	0.00211	0.0037	CcSEcCtD
Moclobemide—Dizziness—Etoposide—muscle cancer	0.00211	0.00369	CcSEcCtD
Moclobemide—Vomiting—Etoposide—muscle cancer	0.00203	0.00355	CcSEcCtD
Moclobemide—Rash—Etoposide—muscle cancer	0.00201	0.00352	CcSEcCtD
Moclobemide—Dermatitis—Etoposide—muscle cancer	0.00201	0.00352	CcSEcCtD
Moclobemide—Headache—Etoposide—muscle cancer	0.002	0.0035	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—muscle cancer	0.002	0.0035	CcSEcCtD
Moclobemide—Chest pain—Methotrexate—muscle cancer	0.00199	0.00349	CcSEcCtD
Moclobemide—Myalgia—Methotrexate—muscle cancer	0.00199	0.00349	CcSEcCtD
Moclobemide—Tension—Doxorubicin—muscle cancer	0.00199	0.00348	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—muscle cancer	0.00199	0.00348	CcSEcCtD
Moclobemide—Discomfort—Methotrexate—muscle cancer	0.00197	0.00345	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—muscle cancer	0.00197	0.00345	CcSEcCtD
Moclobemide—Confusional state—Methotrexate—muscle cancer	0.00193	0.00337	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—muscle cancer	0.00191	0.00335	CcSEcCtD
Moclobemide—Nausea—Etoposide—muscle cancer	0.00189	0.00332	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—muscle cancer	0.00188	0.00329	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—muscle cancer	0.00186	0.00326	CcSEcCtD
Moclobemide—Hyperhidrosis—Methotrexate—muscle cancer	0.00185	0.00323	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—muscle cancer	0.00183	0.0032	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—muscle cancer	0.00182	0.00318	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—muscle cancer	0.00179	0.00314	CcSEcCtD
Moclobemide—Hypotension—Methotrexate—muscle cancer	0.00179	0.00313	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—muscle cancer	0.00178	0.00312	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—muscle cancer	0.00175	0.00306	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00174	0.00305	CcSEcCtD
Moclobemide—Insomnia—Methotrexate—muscle cancer	0.00173	0.00303	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—muscle cancer	0.00173	0.00302	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—muscle cancer	0.00173	0.00302	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—muscle cancer	0.00172	0.00301	CcSEcCtD
Moclobemide—Paraesthesia—Methotrexate—muscle cancer	0.00172	0.003	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—muscle cancer	0.00171	0.00299	CcSEcCtD
Moclobemide—Dyspnoea—Methotrexate—muscle cancer	0.0017	0.00298	CcSEcCtD
Moclobemide—Somnolence—Methotrexate—muscle cancer	0.0017	0.00297	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—muscle cancer	0.00169	0.00296	CcSEcCtD
Moclobemide—Dyspepsia—Methotrexate—muscle cancer	0.00168	0.00295	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—muscle cancer	0.00167	0.00292	CcSEcCtD
Moclobemide—Decreased appetite—Methotrexate—muscle cancer	0.00166	0.00291	CcSEcCtD
Moclobemide—Fatigue—Methotrexate—muscle cancer	0.00165	0.00288	CcSEcCtD
Moclobemide—Shock—Doxorubicin—muscle cancer	0.00163	0.00285	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—muscle cancer	0.00161	0.00283	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—muscle cancer	0.0016	0.0028	CcSEcCtD
Moclobemide—Feeling abnormal—Methotrexate—muscle cancer	0.00157	0.00276	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methotrexate—muscle cancer	0.00156	0.00274	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—muscle cancer	0.00155	0.00271	CcSEcCtD
Moclobemide—Urticaria—Methotrexate—muscle cancer	0.00152	0.00266	CcSEcCtD
Moclobemide—Abdominal pain—Methotrexate—muscle cancer	0.00151	0.00264	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00151	0.00264	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—muscle cancer	0.0015	0.00262	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—muscle cancer	0.00149	0.0026	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—muscle cancer	0.00148	0.00258	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—muscle cancer	0.00147	0.00258	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—muscle cancer	0.00146	0.00255	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—muscle cancer	0.00144	0.00252	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—muscle cancer	0.00143	0.0025	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—muscle cancer	0.00141	0.00248	CcSEcCtD
Moclobemide—Asthenia—Methotrexate—muscle cancer	0.00137	0.0024	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—muscle cancer	0.00136	0.00239	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00135	0.00237	CcSEcCtD
Moclobemide—Pruritus—Methotrexate—muscle cancer	0.00135	0.00237	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—muscle cancer	0.00131	0.0023	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—muscle cancer	0.00131	0.00229	CcSEcCtD
Moclobemide—Diarrhoea—Methotrexate—muscle cancer	0.00131	0.00229	CcSEcCtD
Moclobemide—Dizziness—Methotrexate—muscle cancer	0.00126	0.00221	CcSEcCtD
Moclobemide—Vomiting—Methotrexate—muscle cancer	0.00121	0.00213	CcSEcCtD
Moclobemide—Rash—Methotrexate—muscle cancer	0.0012	0.00211	CcSEcCtD
Moclobemide—Dermatitis—Methotrexate—muscle cancer	0.0012	0.00211	CcSEcCtD
Moclobemide—Headache—Methotrexate—muscle cancer	0.0012	0.0021	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—muscle cancer	0.00119	0.00208	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—muscle cancer	0.00117	0.00205	CcSEcCtD
Moclobemide—Nausea—Methotrexate—muscle cancer	0.00113	0.00199	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—muscle cancer	0.00113	0.00198	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—muscle cancer	0.00109	0.00192	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—muscle cancer	0.00105	0.00184	CcSEcCtD
Moclobemide—Rash—Doxorubicin—muscle cancer	0.00104	0.00183	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—muscle cancer	0.00104	0.00182	CcSEcCtD
Moclobemide—Headache—Doxorubicin—muscle cancer	0.00104	0.00181	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—muscle cancer	0.000983	0.00172	CcSEcCtD
